Literature DB >> 28108880

Unusual Signal Patterns of Break-apart FISH Probes Used in the Diagnosis of Soft Tissue Sarcomas.

Gergő Papp1, Dóra Mihály1, Zoltán Sápi2.   

Abstract

Break-apart FISH probes are the most popular and reliable type of FISH probes used to confirm certain pathological diagnoses. The interpretation is usually easy, however, in some instances it is not so unequivocal. Our aim was to reveal and elucidate the problems occurring in the process of evaluation of the break-apart probe results. Altogether 301 soft tissue sarcomas with confirmed molecular tests using break-apart probes were assessed to reveal the frequency and type of unusual signal pattern. Among 89 synovial sarcoma (SS18) 11%, 12 alveolar rhabdomyosarcoma (FOXO1) 50%, 53 myxoid liposarcoma (DDIT3) 7.5%, 6 low grade fibromyxoid sarcoma (FUS) 67%, 93 Ewing sarcoma (EWSR1) 3%, 12 clear cell sarcoma (EWSR1) 8%, 5 desmoplastic small round cell tumor (EWSR1) 0%, 9 extraskeletal myxoid chondrosarcoma (EWSR1) 0%, 2 myoepithelial carcinoma (EWSR1) 50%, 14 dermatofibrosarcoma protuberans (COL1A1) 86% and 6 nodular fasciitis (USP6) 17% atypical break-apart signals were detected. Despite the unusual signal pattern type, the fusion genes were detected using either metaphase FISH, interphase FISH with translocation/TriCheck probe or RT-PCR methods. Although the interpretation problems in the process to evaluate the break-apart probe results is well known from sporadic case reports, a systemic overview to detect their frequency has not been performed so far. In our work we highlighted the relative frequency of this problem and pinpointed those signal-patterns which, despite their unusual appearance, can still confirm the diagnosis.

Entities:  

Keywords:  Atypical FISH pattern; Break-apart probe; Soft tissue sarcoma

Mesh:

Year:  2017        PMID: 28108880     DOI: 10.1007/s12253-017-0200-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

1.  Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma.

Authors:  Károly Szuhai; Marije IJszenga; Hans J Tanke; Antonie H M Taminiau; Arthur de Schepper; Sjoerd G van Duinen; Carla Rosenberg; Pancras C W Hogendoorn
Journal:  Cancer Genet Cytogenet       Date:  2007-01-01

Review 2.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

3.  Unknown partner for USP6 and unusual SS18 rearrangement detected by fluorescence in situ hybridization in a solid aneurysmal bone cyst.

Authors:  Katherine Geiersbach; Lyndsey S Rector; Maria Sederberg; Ana Hooker; R Lor Randall; Joshua D Schiffman; Sarah T South
Journal:  Cancer Genet       Date:  2011-04

Review 4.  Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.

Authors:  Nicolas Sirvent; Georges Maire; Florence Pedeutour
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

5.  Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.

Authors:  J M Berner; A Forus; A Elkahloun; P S Meltzer; O Fodstad; O Myklebost
Journal:  Genes Chromosomes Cancer       Date:  1996-12       Impact factor: 5.006

6.  Complex rearrangement of chromosomes 1, 7, 21, 22 in Ewing sarcoma.

Authors:  Natini Jinawath; Laura Morsberger; Alexis Norris-Kirby; Lisa M Williams; Raluca Yonescu; Pedram Argani; Constance A Griffin; Kathleen M Murphy
Journal:  Cancer Genet Cytogenet       Date:  2010-08

Review 7.  Soft tissue tumors associated with EWSR1 translocation.

Authors:  Salvatore Romeo; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

8.  Advantage of FISH analysis using FKHR probes for an adjunct to diagnosis of rhabdomyosarcomas.

Authors:  Tadaki Matsumura; Takehiko Yamaguchi; Kunihiko Seki; Tadakazu Shimoda; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

9.  Translocations and amplifications of chromosome 12 in liposarcoma demonstrated by the LSI CHOP breakapart rearrangement probe.

Authors:  Carlynn Willmore-Payne; Joseph Holden; Kristi C Turner; Alan Proia; Lester J Layfield
Journal:  Arch Pathol Lab Med       Date:  2008-06       Impact factor: 5.534

10.  Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.

Authors:  Pedram Argani; Sebastian Aulmann; Zarir Karanjawala; Robert B Fraser; Marc Ladanyi; Maria M Rodriguez
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

View more
  10 in total

1.  Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Authors:  Ambrus Gángó; Bence Bátai; Martin Varga; Dóra Kapczár; Gergő Papp; Márta Marschalkó; Enikő Kuroli; Tamás Schneider; Judit Csomor; András Matolcsy; Csaba Bödör; Ágota Szepesi
Journal:  Virchows Arch       Date:  2018-06-01       Impact factor: 4.064

2.  USP6 activation in nodular fasciitis by promoter-swapping gene fusions.

Authors:  Nimesh R Patel; John S A Chrisinger; Elizabeth G Demicco; Stephen F Sarabia; Jacquelyn Reuther; Erica Kumar; Andre M Oliveira; Steven D Billings; Judith V M G Bovée; Angshumoy Roy; Alexander J Lazar; Dolores H Lopez-Terrada; Wei-Lien Wang
Journal:  Mod Pathol       Date:  2017-07-28       Impact factor: 7.842

3.  Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence In Situ Hybridization Detection for NCOA2 Rearrangement.

Authors:  Canming Wang; Yuqian Fan; Jianguo Wei; Qiujie Xu; Guoqing Ru; Ming Zhao
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

4.  Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation.

Authors:  Abhijit Chougule; Martin S Taylor; Valentina Nardi; Ivan Chebib; Gregory M Cote; Edwin Choy; G Petur Nielsen; Vikram Deshpande
Journal:  Am J Surg Pathol       Date:  2019-02       Impact factor: 6.394

5.  High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.

Authors:  Martin F Orth; Tilman L B Hölting; Marlene Dallmayer; Fabienne S Wehweck; Tanja Paul; Julian Musa; Michaela C Baldauf; Didier Surdez; Olivier Delattre; Maximilian M L Knott; Laura Romero-Pérez; Merve Kasan; Florencia Cidre-Aranaz; Julia S Gerke; Shunya Ohmura; Jing Li; Aruna Marchetto; Anton G Henssen; Özlem Özen; Shintaro Sugita; Tadashi Hasegawa; Takayuki Kanaseki; Stefanie Bertram; Uta Dirksen; Wolfgang Hartmann; Thomas Kirchner; Thomas G P Grünewald
Journal:  Cancers (Basel)       Date:  2020-03-10       Impact factor: 6.639

6.  Clinicopathological and molecular study of 10 salivary gland clear cell carcinomas, with emphasis on rare cases with high grade transformation and occurring in uncommon sites.

Authors:  Lanlan Xuan; Suxia Wang; Jianguo Wei; Jianwei Yuan; Honggang Liu
Journal:  Diagn Pathol       Date:  2022-01-30       Impact factor: 2.644

Review 7.  The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.

Authors:  Michele Fiore; Andrea Sambri; Paolo Spinnato; Riccardo Zucchini; Claudio Giannini; Emilia Caldari; Maria Giulia Pirini; Massimiliano De Paolis
Journal:  Curr Treat Options Oncol       Date:  2021-10-23

8.  Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets.

Authors:  Michaela C Baldauf; Martin F Orth; Marlene Dallmayer; Aruna Marchetto; Julia S Gerke; Rebeca Alba Rubio; Merve M Kiran; Julian Musa; Maximilian M L Knott; Shunya Ohmura; Jing Li; Nusret Akpolat; Ayse N Akatli; Özlem Özen; Uta Dirksen; Wolfgang Hartmann; Enrique de Alava; Daniel Baumhoer; Giuseppina Sannino; Thomas Kirchner; Thomas G P Grünewald
Journal:  Oncotarget       Date:  2017-08-04

9.  Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma.

Authors:  Levente Kuthi; Áron Somorácz; Tamás Micsik; Alex Jenei; Adrienn Hajdu; István Sejben; Dániel Imre; Boglárka Pósfai; Katalin Kóczián; Dávid Semjén; Zoltán Bajory; Janina Kulka; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2020-01-18       Impact factor: 3.201

10.  FOXO1 gene involvement in a non-rhabdomyosarcomatous neoplasm.

Authors:  Matthias S Matter; Beata Bode-Lesniewska; Simon Haefliger; Muriel Genevay; Michel Bihl; Romina Marone; Daniel Baumhoer; Michael Papaloizos
Journal:  Virchows Arch       Date:  2021-01-28       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.